17th Jul 2007 07:00
Premier Research Group17 July 2007 For Immediate Release 17 July 2007 Premier Research Group appoints Dr Peter Fellner as Non-executive Chairman Premier Research Group plc (AIM: PRG), the international pharmaceutical servicesgroup, is pleased to announce that it has appointed Peter Fellner (63) asNon-executive Chairman, with effect from 1 September 2007. Dr Fellner was CEO of Celltech plc from 1990 to 2003, and Chairman from 2003until it was acquired by UCB in 2004 for £1.53 billion. He oversaw its growthfrom a small research-based company to the UK's largest biotech company. Dr Fellner continues to have significant involvement in the pharmaceutical/biotech sector. He is currently Chairman of Vernalis plc, Acambis plc and AstexTherapeutics Ltd. He is also a Director of UCB SA, a global biopharma leader,and in addition serves as a Director of Bespak plc, Evotec AG and QinetiQ Groupplc, one of Europe's leading technology companies. Before Celltech, he was CEO of Roche UK from 1986 to 1990, having previouslybeen Director of the Roche UK Research Centre from 1984 to 1986. Commenting on Dr Fellner's appointment, Premier Research Group CEO, Simon Yaxleysaid: "We are delighted to have attracted someone of Peter's calibre and reputation tothe Board of Premier Research. His appointment represents the next step in ourcommitment to shareholders to strengthen the Board. The search is alreadyunderway for a further non-executive director with a strong finance backgroundto head the audit committee. We would also like to thank Steve Harris forfilling the role of interim chairman until Peter's appointment and look forwardto Steve's continued involvement with the Company as he steps back into hisposition of senior non-executive director." Enquiries:Premier Research Group plc Tel: 01344 752375 Dr Simon Yaxley, Chief Executive Officerwww.premier-research.com-------------------------- Buchanan Communications Tel: 020 7466 5000 Lisa BaderoonRebecca Skye Dietrich Evolution Securities Tel: 020 7071 4300 Simon Leathers About Premier Research Premier Research is a growing contract research organisation (CRO) involved inthe design and execution of clinical trials (Phases II-IV) on behalf ofpharmaceutical and biotechnology companies. Premier is established in threetherapeutic areas - oncology, CNS (central nervous system) and anti-infectives -with a strong underlying expertise in paediatrics. Through a focused approach toclinical management, the company has built a reputation with its customers fordelivery of its services. Premier has also established itself as an activeparticipant in the consolidation activity within the sector. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PRG.L